CXCL8 and breast carcinoma: Studies show that CXC chemokine ligand 8 (CXCL8 or IL-8) promotes the EMT of human breast cancer cells via the formation of the TWIST1-p65 complex that activates transcription of NF-κB and increases the binding affinity of p65 to CXCL8 [68].